Researchers at the Berlin Institute of Health in the Charité (BIH) have teamed up with colleagues from Cellbricks to develop a 3D printer that can produce a biological wound closure. The development is intended to reach high altitudes and help…
ProBioGen was founded in Berlin in 1994, and has been part of the Egyptian Minapharm Group since 2010. The biotech company and its subsidiary MiGenTra operate around the globe and have years of experience developing and producing biopharmaceuticals…
GrownValve is a spin-off of the Deutsches Herzzentrum Berlin and Charité. The company was founded in 2019. It develops patient-specific, endogenous heart valves, with a focus on pediatrics. We interview Jasper Emeis, research associate of GrOwnValve…
Björn von Siemens is co-founder and managing director of caresyntax GmbH. The company develops algorithms that analyze risk factors during surgery and provide decision support. The company, based in Berlin and Boston, recently raised 100 million US…
Double interview with Prof. Dr. Christian Drosten, Director of the Institute of Virology at Charité Berlin and speaker at the World Health Summit, and Prof. Dr. Detlev Ganten, President and Founder of the World Health Summit.
At the beginning of 2019, the British foundation Wellcome Trust opened an office in Berlin, thus expanding its activities to Germany. The first project funded by the foundation in Germany is a translation partnership with the Berlin Institute of…
Healthcare is one of the most exciting sectors that is expected to fully embrace the development of 3-D printing. Patients and providers alike are looking to a future where the custom fabrication of prostheses, implants, and most likely even whole…
Nikolaus Rajewsky studied mathematics and physics in his hometown of Cologne. After earning his doctorate, he spent time abroad in New Jersey and New York. In 2006, the 50-year-old returned to Germany and has since been Professor of Systems Biology…
Biologist Peter Albiez started his career at Pfizer in 1996 as a pharmaceuticals consultant. Following management positions in sales and marketing, he took over the management of Pfizer's sales organization in 2006. In 2009, he was appointed managing…
